In general, patients have a poor prognosis and exhibit symptoms such as pain, fever, weight loss, obezitate, and nulipare. However, there is a small percentage of women under 40 who will develop the disease. However, there are ways to detect cancer endometrial in women.
The diagnosis of cancer endometrial in women is based on a review of the medical history and a physical exam. The physical examination includes palpation for any lumps or changes in the shape of the uterus. Usually, stage IIB cancer has spread to the tissues surrounding the uterus. Stage IIB2 and IIIC cancers are larger than 2 cm. Stage IIIC cancer involves lymph nodes in the pelvic cavity and may cause non-functioning or hydronephrosis.
Although the risk of developing cancer after treatment for endometrial cancer is low, it is possible to develop another type. Those with high-grade endometrial cancer are at greater risk of developing a second type of cancer, including serous and mixed epithelial cancers. Additionally, women with clear cell types are at higher risk of developing breast and colon cancer. Although there are no known risk factors, being over 50 and female tends to increase the risk of developing cancer of the endometrium.
Symptoms of endometrial cancer depend on the age of the patient, her health status, and the use of hormone therapy. While estrogen therapy is thought to reduce some of the symptoms associated with endometrial cancer, many doctors and patients ignore the symptoms. Because perimenopausal sangerare can be normal without a macroscopic boala, many women may be unaware of the problem. However, the symptoms of endometrial cancer may be subtle.
There are several types of endometrial cancer, categorized according to their location. The most common type is adenocarcinoamele endometrioide. Adenocarcinoame has a benign component, but is a malignant component. In addition, adenocarcinoamoid may involve the endometrium, the uterine boala, and the miometrium.
CT toracic imaging is a screening tool used to evaluate cancer in the pelvis. In addition to the RMN pelvic x-ray, CT toracica is a type of pelvic x-ray that uses no contrast. Both of these tests are useful for evaluating endometrial cancer and to differentiate it from other types. CT toracic/abdominal/pelvin combines a CT scan of the pelvis and abdominal region.
Chemotherapy is also a treatment option. Two chemotherapy regimens, everolimus and letrozol, are currently in clinical trials. In combination, they show a 32% response rate. During clinical trials, the tumors stabilized with letrozol. In addition, bevacizumab has demonstrated a high response rate, which makes it a promising option for recurrent endometrial cancer patients.
